•
MR
MRK
Merck & Co., Inc.
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
271.66B
Volume
12.84M
52W High
$112.90
52W Low
$73.31
Open
$109.19
Prev Close
$109.45
Day Range
108.73 - 111.97
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Latest News
Moderna Stock Rallies as Oncology Results Improve the Platform’s Value Case
Investing.com•9h ago
High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider
GlobeNewswire Inc.•13h ago
Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative
Investing.com•14h ago
Moderna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma
Benzinga•Yesterday
Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report
Benzinga•Yesterday
Tenosynovial Giant Cell Tumors Market to Show Significant Growth by 2034 as CSF1R-Targeted Therapies Drive the Next Wave | DelveInsight
GlobeNewswire Inc.•Jan 19
Canine Vaccines Market Size to Reach USD 3.45 Billion by 2033, Supported by Rising Pet Ownership and Preventive Animal Healthcare Focus – SNS Insider
GlobeNewswire Inc.•Jan 16
FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (UPDATED)
Benzinga•Jan 16